Moehs Group, a reference company in the production of pharmaceutical active ingredients.
01 1Moehs Catalana SL
02 1AX Pharmaceutical Corp
03 1Abhilasha Pharma Pvt. Ltd.
04 1Cambrex Karlskoga AB
05 1DISHMAN CARBOGEN AMCIS LIMITED
06 1Excella GmbH & Co. KG
07 1Fagron Inc
08 1LETCO MEDICAL, LLC
09 1Medisca Inc.
10 1Pharma Source Direct, Inc.
11 1Professional Compounding Centers of America
12 2Professional Compounding Centers of America dba PCCA
13 1Siegfried Evionnaz SA
14 1Societa Italiana Medicinali Scandicci S.I.M.S., SrL
15 1Spectrum Laboratory Products, Inc.
16 1Willow Birch Pharma, Inc.
01 6BUPIVACAINE HYDROCHLORIDE
02 1BUPIVACAINE HYDROCHLORIDE MONOHYDRATE
03 1Bupivacaine HCL
04 4Bupivacaine HCl
05 4Bupivacaine Hydrochloride
06 1Bupivacaine Hydrochloride monohydrate
01 1Canada
02 2India
03 1Italy
04 1Luxembourg
05 1Netherlands
06 1Spain
07 1Switzerland
08 6U.S.A
09 3United Kingdom
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0729
Start Marketing Date : 2009-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12651-111
Start Marketing Date : 2016-07-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0456
Start Marketing Date : 1998-04-01
End Marketing Date : 2027-07-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 46014-1113
Start Marketing Date : 2007-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0524
Start Marketing Date : 2012-11-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0232
Start Marketing Date : 2022-02-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17381-074
Start Marketing Date : 2010-05-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12660-0391
Start Marketing Date : 1979-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-1313
Start Marketing Date : 1996-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-038
Start Marketing Date : 2017-04-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Bupivacaine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bupivacaine Hydrochloride, including repackagers and relabelers. The FDA regulates Bupivacaine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bupivacaine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bupivacaine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bupivacaine Hydrochloride supplier is an individual or a company that provides Bupivacaine Hydrochloride active pharmaceutical ingredient (API) or Bupivacaine Hydrochloride finished formulations upon request. The Bupivacaine Hydrochloride suppliers may include Bupivacaine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Bupivacaine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bupivacaine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bupivacaine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bupivacaine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bupivacaine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bupivacaine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bupivacaine Hydrochloride suppliers with NDC on PharmaCompass.
We have 15 companies offering Bupivacaine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
